News

Shares of global vaccine makers were mixed on Tuesday, as investors assessed U.S. Health Secretary Robert F. Kennedy Jr.'s ...
(Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach ...
While the news isn’t great for vaccine manufacturers, it could have been worse. Shares of pure vaccine play Moderna rose 0.3% ...
Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...
Robert F. Kennedy Jr. faced questions from Congress about his own potential conflicts of interest during a confirmation ...
Headlines blared in May when U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. announced that the ...
Health and Human Services Secretary Robert F. Kennedy Jr.’s moves to upend decades of vaccine policy could hit patients hardest in their wallets, as shifting guidance over shots could make ...
BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech ...
Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...
A day after abruptly firing a key vaccine panel, RFK Jr. said he would reconstitute it with “highly credentialed" experts ...
The new appointees include Vicky Pebsworth, a regional director for the National Association of Catholic Nurses. She has been ...
A sweeping overhaul of the CDC's top vaccine advisory panel is ripping through the medical world, while rattling pharma and ...